Summary
A 23-year-old male applicant was denied a security clearance under Guideline H (Drug Involvement) due to multiple admitted instances of illegal drug use and possession. The Statement of Reasons detailed his use of marijuana from approximately November 2010 until at least December 2018, including a purchase of about 3.5 ounces.
Further allegations included the use of illegal hallucinogenic mushrooms in June 2017, LSD in August 2015, and cocaine in February 2015. The applicant also admitted to using prescription medications not prescribed to him, specifically Adderall from February 2015 to May 2017, Hydrocodone on multiple occasions in November 2015, and recreational Xanax from February 2012 to October 2015.
The administrative judge found that the applicant failed to mitigate these concerns. The continued drug use into his twenties raised questions about his reliability and trustworthiness, and he did not provide sufficient evidence of rehabilitation or a commitment to abstain from future drug use. Consequently, the security clearance application was denied.
Why the Applicant Was Denied
- The applicant admitted to multiple instances of illegal drug use and possession, including marijuana and prescription medications not prescribed to him.
- The applicant's drug use continued into his 20s, raising questions about his reliability and trustworthiness.
- The applicant failed to provide sufficient evidence of rehabilitation or a commitment to abstain from drug use.
Conditions Referenced
- AG ¶ 25(a)raisedSubstance Misuse
- AG ¶ 25(c)raisedIllegal Possession of a Controlled Substance
Key Rule Quoted
“A person who seeks access to classified information enters into a fiduciary relationship with the Government predicated upon trust and confidence.”
Procedural Posture
- SOR issuedJan 9, 2019
- Answer filedJan 30, 2019Applicant admitted allegations.
- Hearing held—Decision based on written record.
- Decision dateMay 30, 2019
Cite For
- Denial of Security Clearance Due to Ongoing Drug Involvement
- Importance of Demonstrating Rehabilitation for Drug-related Concerns
- Evaluation of Reliability and Trustworthiness Under Guideline H